Initial Experience With Lung Cancer Resection Following Treatment With T Cell Checkpoint Inhibitor Therapy

T cell checkpoint inhibitors targeting the programmed death receptor-1 (PD-1) and its ligand (PDL-1) have recently been approved for the treatment of metastatic non-small cell lung cancer (NSCLC), but their safety and efficacy as neoadjuvant therapy are still undefined. Autoimmune toxicities, notabl...

Full description

Saved in:
Bibliographic Details
Published in:Ann Thorac Surg
Main Authors: Chaft, Jamie E., Hellmann, Matthew D., Velez, Moises J., Travis, William D., Rusch, Valerie W.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572805/
https://ncbi.nlm.nih.gov/pubmed/28838509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2017.03.038
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items